Population
Individuals with Spinal muscular atrophy (SMA) and potential carriers
Design
Review
Authors
Loading...
May inform SMA screening policy; leaves open prospective trials on implementation, equity, and long-term outcomes.
Newborn and carrier screening for SMA are crucial strategies for early intervention and prevention of new cases while effective treatments are being developed.
Thomas W. Prior (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: